Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...

Editor's Note: APYs listed in this article are up-to-date as of the time of publication. They may fluctuate (up or down) as the Fed rate changes. CNBC Select will update as changes are made public.

Google Maps now requires you to sign in to get all the perks, but it's probably worth it. Use these tips to remember parking spots, access maps offline, share your location, and more. My PCMag career ...